Scarica l'app Stockscreener
11.01
4.46%
0.47
Dopo l'orario di chiusura:
10.94
-0.07
-0.64%
Precedente Chiudi:
$10.54
Aprire:
$10.63
Volume 24 ore:
82,429
Relative Volume:
0.44
Capitalizzazione di mercato:
$238.09M
Reddito:
-
Utile/perdita netta:
$-35.46M
Rapporto P/E:
-26.10
EPS:
-0.4218
Flusso di cassa netto:
$-34.00M
1 W Prestazione:
-0.36%
1M Prestazione:
-6.30%
6M Prestazione:
+167.88%
1 anno Prestazione:
-34.31%
Intervallo 1D:
$10.36
$11.01
Intervallo di 1 settimana:
$10.36
$11.34
Portata 52W:
$3.35
$20.24
Contineum Therapeutics Inc Stock (CTNM) Company Profile
Nome
Contineum Therapeutics Inc
Settore
Industria
Telefono
(858) 333-5280
Indirizzo
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO
Confronta CTNM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTNM
Contineum Therapeutics Inc
|
11.01 | 295.56M | 0 | -35.46M | -34.00M | -0.4218 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Contineum Therapeutics Inc Stock (CTNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-25 | Iniziato | Leerink Partners | Outperform |
| 2025-06-20 | Iniziato | William Blair | Outperform |
| 2024-10-22 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-30 | Iniziato | Morgan Stanley | Overweight |
| 2024-04-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-04-30 | Iniziato | Stifel | Buy |
Mostra tutto
Contineum Therapeutics Inc Borsa (CTNM) Ultime notizie
How Contineum Therapeutics Inc. stock reacts to inflationary pressuresWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
What momentum shifts mean for Contineum Therapeutics Inc.2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com
Live market analysis of Contineum Therapeutics Inc.Weekly Investment Report & AI Based Buy and Sell Signals - newser.com
Risk adjusted return profile for Contineum Therapeutics Inc. analyzedGap Down & Free Real-Time Volume Trigger Notifications - newser.com
Will Contineum Therapeutics Inc. stock split attract more investors2025 Major Catalysts & Consistent Profit Alerts - newser.com
Contineum Therapeutics Inc. stock momentum explainedJuly 2025 Short Interest & Smart Money Movement Alerts - newser.com
Using Ichimoku Cloud for Contineum Therapeutics Inc. technicalsJuly 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Why retail investors pile into Contineum Therapeutics Inc. stockEarnings Overview Summary & Capital Protection Trade Alerts - newser.com
Can Contineum Therapeutics Inc. stock outperform in 2025 bull marketInsider Selling & Real-Time Price Movement Reports - newser.com
Contineum Therapeutics (NASDAQ:CTNM) Issues Quarterly Earnings Results - MarketBeat
Using data models to predict Contineum Therapeutics Inc. stock movementPortfolio Gains Report & Daily Technical Stock Forecast Reports - newser.com
Buy Rating for Contineum Therapeutics: Promising Advancements in Clinical Pipeline and Strategic Opportunities - TipRanks
How Contineum Therapeutics Inc. stock compares to growth peersJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Is Contineum Therapeutics Inc. building a consolidation baseWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
What makes RF Acquisition Corp II stock price move sharply - newser.com
Building trade automation scripts for Contineum Therapeutics Inc.2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Is it time to cut losses on Contineum Therapeutics Inc.2025 Sector Review & Real-Time Market Sentiment Reports - newser.com
Contineum Therapeutics Reports Increased R&D Investment Amid Losses - TipRanks
Is Contineum Therapeutics Inc. stock attractive for growth ETFsJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Visual trend scoring systems applied to Contineum Therapeutics Inc.July 2025 Patterns & Daily Profit Maximizing Tips - newser.com
Volatility clustering patterns for Contineum Therapeutics Inc.Portfolio Risk Summary & Pattern Based Trade Signal System - newser.com
[10-Q] Contineum Therapeutics, Inc. Quarterly Earnings Report | CTNM SEC FilingForm 10-Q - Stock Titan
CTNM 8-K: Q3 2025 results press release furnished (Exhibit 99.1) - Stock Titan
Contineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
Contineum Therapeutics (CTNM) Expected to Announce Earnings on Wednesday - MarketBeat
Contineum Therapeutics Inc Azioni (CTNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):